What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Acquired immunodeficiency syndrome
His primary areas of investigation include Immunology, Internal medicine, Virology, Acquired immunodeficiency syndrome and Virus.
His research related to Immunopathology, Viral disease, Antigen, Lymphocyte and T cell might be considered part of Immunology.
His research integrates issues of Gastroenterology and Surgery in his study of Internal medicine.
His Virology research is multidisciplinary, relying on both Efavirenz, CD8 and Genetic enhancement.
His Acquired immunodeficiency syndrome study integrates concerns from other disciplines, such as Epidemiology, Circulating MicroRNA, microRNA and Case-control study.
His work deals with themes such as Peripheral blood mononuclear cell, B cell and Toxoid, which intersect with Virus.
His most cited work include:
- Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study (2421 citations)
- Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. (688 citations)
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome (552 citations)
What are the main themes of his work throughout his whole career to date?
Ronald T. Mitsuyasu mainly focuses on Immunology, Internal medicine, Acquired immunodeficiency syndrome, Oncology and Virology.
Immune system, Immunopathology, Virus, Viral disease and Antigen are subfields of Immunology in which his conducts study.
His Internal medicine research incorporates themes from Gastroenterology and Surgery.
His research integrates issues of Clinical trial, Incidence, Sarcoma and Pathogenesis in his study of Acquired immunodeficiency syndrome.
Ronald T. Mitsuyasu has included themes like Cetuximab, Chemotherapy regimen, Anal canal, Lymphoma and Radiation therapy in his Oncology study.
His Virology research is multidisciplinary, relying on both Interleukin 2 and CD8.
He most often published in these fields:
- Immunology (52.17%)
- Internal medicine (44.93%)
- Acquired immunodeficiency syndrome (31.40%)
What were the highlights of his more recent work (between 2015-2020)?
- Internal medicine (44.93%)
- Oncology (20.77%)
- EPOCH (7.73%)
In recent papers he was focusing on the following fields of study:
Ronald T. Mitsuyasu focuses on Internal medicine, Oncology, EPOCH, Lymphoma and Rituximab.
Internal medicine is often connected to Viral load in his work.
His research in Oncology intersects with topics in Cetuximab, Anal canal, Immunology, Immune system and Radiation therapy.
His Immunology study often links to related topics such as Graft-versus-host disease.
His biological study spans a wide range of topics, including Virology and AIDS-Related Non-Hodgkin Lymphoma.
His Cancer study combines topics from a wide range of disciplines, such as Hiv epidemic, Acquired immunodeficiency syndrome, Body mass index and Paclitaxel carboplatin.
Between 2015 and 2020, his most popular works were:
- The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies (61 citations)
- Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection. (45 citations)
- HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers (41 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Immune system
Ronald T. Mitsuyasu spends much of his time researching Internal medicine, EPOCH, Oncology, Lymphoma and Treatment interruption.
His studies deal with areas such as Gastroenterology and Surgery as well as Internal medicine.
Ronald T. Mitsuyasu combines subjects such as Cranial Irradiation and Chemotherapy with his study of Lymphoma.
His Treatment interruption research is multidisciplinary, incorporating perspectives in Peripheral blood mononuclear cell, Genome and CD8, Immune system.
The concepts of his Young adult study are interwoven with issues in Record linkage, Cervical cancer, Cancer registry and Acquired immunodeficiency syndrome.
His Cancer study integrates concerns from other disciplines, such as Proportional hazards model, Immunology, Cohort and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
